Akdital (CAS:AKT) Loans Receivable: MAD0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAS:AKT Akdital CAS:AKT
84 GF Score
Price MAD1,139.00
GF Value MAD2,196.11
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Akdital Loans Receivable?

Akdital CAS:AKT +1.42% 84 Loans Receivable is MAD0 Mil as of Dec. 2025. GuruFocus rates CAS:AKT with a GF Score™ of 84/100 and a GF Value™ of MAD2,196.11 (Possible Value Trap). The stock has 5 warning signs investors should review.

Akdital's Loans Receivable for the quarter that ended in Dec. 2025 was MAD0 Mil.

Akdital Loans Receivable Historical Data

* Premium members only.

The historical data trend for Akdital's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akdital Loans Receivable Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CAS:AKT
84GF Score
Akdital CAS:AKT
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akdital Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of MAD0 Mil mean?
Akdital (CAS:AKT) has a Loans Receivable of MAD0 Mil as of Dec. 2025. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Akdital and its competitors.
Is Akdital's Loans Receivable too high?
Akdital's current Loans Receivable is MAD0 Mil. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Loans Receivable compare to HCA and THC?
Akdital's Loans Receivable of MAD0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Healthcare Providers & Services company?
A good Loans Receivable depends on the Healthcare Providers & Services industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Akdital and its competitors. Akdital's current Loans Receivable is MAD0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,196.11, compared to a current price of MAD1,139.00 — trading 48.1% below its estimated fair value. The current Loans Receivable is MAD0 Mil. Akdital's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Loans Receivable is MAD0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akdital (CAS:AKT) Overvalued in 2026?

Based on GuruFocus' analysis, Akdital stock appears to be undervalued. The current stock price of MAD1,139.00 is trading 48.1% below its estimated GF Value™ of MAD2,196.11. GuruFocus considers Akdital to be Possible Value Trap.

Key valuation signals for CAS:AKT:

  • Loans Receivable: MAD0 Mil
  • GF Value™: MAD2,196.11 vs. price of MAD1,139.00 (48.1% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akdital Business Description

Address 246 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score

Get the complete analysis for CAS:AKT

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD1,139.00
Price
MAD2,196.11
GF Value